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Abstract
This paper provides a perspective on epidemiological research on radiation and cancer, a field that has evolved
over its six decade history. The review covers the current framework for assessing radiation risk and persistent
questions about the details of these risks: is there a threshold and more generally, what is the shape of the dose-
response relationship? How do risks vary over time and with age? What factors modify the risk of radiation? The
example of radon progeny and lung cancer is considered as a case study, illustrating the modeling of
epidemiological data to derive quantitative models and the coherence of the epidemiological and biological
evidence. Finally, the manuscript considers the need for ongoing research, even in the face of research over a 60-
year span.
Introduction
Ionizing radiation was discovered in 1895 by Wilhelm
Conrad Roentgen, and its utility for diagnostic purposes
was quickly recognized. By 1902, the first radiation-
caused skin cancer was identified and the first radiation-
caused leukemia case followed in 1911. Several clusters
of radiation-caused cancer were described over the
ensuing decades: radon and lung cancer in underground
metal miners in eastern Europe, and osteogenic sarcoma
in radium dial painters. In 1944, based on more formal
epidemiological inquiry, an excess of leukemia was
reported among radiologists in the United States [1]. By
World War II, there was sufficient understanding of the
risks of radiation to motivate a program of protection
for workers at the Manhattan Project in the United
States [2].
Radiation epidemiology was launched when a program
of studies was initiated by the then Atomic Bomb
Casualty Commission (eventually to become the Radia-
tion Effects Research Foundation) to determine the con-
sequences of radiation exposure from the nuclear blasts
at Hiroshima and Nagasaki [3,4]. A large, prospective
cohort was designed, the Lifespan Study of 120,000 sur-
vivors, which is still in progress. This cohort has proved
to be a remarkably informative resource, providing a
temporal profile of leukemia and cancer associated with
the blast and a robust data set for making quantitative
estimates of risk. Many cohort studies have followed
with radiation exposures received through therapeutic
intervention or occupation, or by accident. The resulting
data base is extensive for several types of radiation
including X and gamma radiation and radon. The data
have been sufficient to support a radiation protection
approach that is grounded in the epidemiological evi-
dence (see below).
Risk assessment, radiation, and cancer
Radiation exposures are ubiquitous, coming from medi-
cal and industrial applications and from naturally occur-
ring sources. Exposures are regulated through an
evidence-based approach that is used to characterize
risks, drawing primarily on the epidemiological evidence
(Figure 1). Risk assessment is an applied methodology,
used to characterize risks to populations as the basis for
risk management [5]. A 1983 report of the United States
National Research Council, Risk Assessment in the Fed-
eral Government: Managing the Process (widely referred
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assessment: hazard identification (is there a problem?),
dose-response assessment (how does risk vary with dose
or exposure?), exposure assessment (what is the popula-
tion’s pattern of exposure?), and risk characterization
(what is the magnitude of the problem and what are the
key uncertainties in that understanding?) [6]. Many sub-
sequent reports from the National Research Council and
other groups have refined the elements of risk assess-
ment, though the four components have proved to be
invaluable in approaching risk questions. The framework
is useful, not only for assembling evidence on risk, but
for identifying evidence gaps, attendant uncertainties,
and related research needs. Most recently, a National
Research Council Committee gave emphasis to the need
to make certain that questions were properly framed to
assure that the findings of a risk assessment will prove
valuable for risk management [5].
Risk assessment has become fundamental to strategies
for limiting cancer risks associated with radiation expo-
sures. There is a need to minimize risk at the popula-
tion level and to assure that risks to individuals do not
reach unacceptable levels, particularly for workplace
exposures. Determination of the acceptability of risk
requires an assessment of the magnitude of risk and a
societal judgment as to acceptability of the estimated
risk [7]. We are also learning that there is a spectrum of
susceptibility to radiation that needs to be taken into
account. Additionally, the millions of people receiving
radiation for diagnostic and therapeutic purposes need
to have an understanding of the attendant risks. Such
medical exposures have now surpassed radon as the
leading contributor to radiation exposure in the United
States as use of diagnostic imaging has risen sharply [8].
For ionizing radiation, the principal uncertainty at pre-
sent lies in the form of the dose-response relationship.
There is no doubt as to the existence of a hazard and
exposures are known with reasonable accuracy. How-
ever, at “low levels” uncertainty persists as to whether
the dose-response relationship is linear and whether
there is a dose threshold, below which there is no risk.
Some have proposed that “low” exposures to radiation
may be beneficial, a hypothesis referred to as “hormesis”
[9]. This controversy is discussed subsequently in this
manuscript. Over recent decades, various expert groups
have adopted linear no-threshold dose-response models
for radiation and cancer, based on review of epidemiolo-
gical and biological evidence. This assumption is impor-
tant because it assigns risk to any exposure and the
burden of cancer attributable to radiation is conse-
quently driven by the lower levels of exposure that con-
tribute the bulk of the radiation dose to the population.
Radon, epidemiology, and risk
Radon, a noble gas resulting from the decay of naturally
occurring uranium-238, has been extensively studied
using epidemiological methods, initially to characterize
the risks faced by radon-exposed underground miners
so as to promulgate protective standards and subse-
quently to estimate the risks of radon exposure in
homes so as to develop guidelines for acceptable indoor
concentrations [10]. The half-century of epidemiological
Figure 1 Evidence-based radiation protection.
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and in homes demonstrates the utility of observational
studies for addressing societal questions on cancer risk
and for guiding risk management approaches. Under-
ground mines may have substantial levels of radon,
which comes from the ore or from water in the mine.
Radon is ubiquitous in homes, sometimes at concentra-
t i o n sa sh i g ha st h o s em e a s u r e di nm i n e s ,b u tm o r e
often at far lower levels. The predominant source for
indoor radon is soil gas containing radon produced by
the natural decay of uranium.
Radon, the first occupational respiratory carcinogen to
be identified, is an alpha-emitter that decays with a half-
life of 3.5 days to a short-lived series of progeny [11].
Several of the short-lived progeny are also alpha-emit-
ters and their alpha decays deliver the energy to target
cells in the respiratory epithelium that is considered to
cause radon-associated lung cancer [11]. Elegant labora-
tory research using single alpha particles demonstrates
that one-hit of an alpha particle to a cell can lead to
permanent change and also to “by-stander” effects on
adjacent cells. The energy delivered to a cell from the
alpha particles released by radon progeny is invariant
with dose, reflecting the energy inherent to the decay
process itself. These findings and dosimetric considera-
tions have been interpreted as strongly supporting a no-
threshold relationship between exposure and risk [11].
When the evidence on radon and cancer is considered
within a causal assessment framework, the evidence was
sufficient to identify radon as causally associated with
lung cancer by the 1960s. By then, the substantial excess
of lung cancer in radon-exposed Eastern European
miners had been documented and the findings of sev-
eral, more formal epidemiological studies of under-
ground miners had been published, most notably the
study of Colorado Plateau uranium miners in the United
States [12]. Additionally, the dosimetry of radon progeny
in the lung had been worked out and ionizing radiation
generally had been established as a cause of cancer. Sub-
sequently, the results of additional confirmatory epide-
miological studies of underground miners were
published [13]. In 1988, IARC reviewed the evidence,
reaching the conclusion that radon and its decay pro-
ducts are a Group I carcinogen; as a member of the
Working Group, I recall that this conclusion was
reached quickly and without controversy, given the
extensive human and biological evidence available [14].
The resulting epidemiological data were sufficiently
robust to support analyses to develop epidemiologically-
based risk models. As the epidemiological data strength-
ened, the models moved from being based in single
s t u d i e st op o o l e dd a t af r o mm u l t i p l es t u d i e s( f o ra
description of these models, see the Biological Effects of
Ionizing Radiation (BEIR) IV and BEIR VI reports of the
US National Research Council [11,15]). These larger
data sets facilitated the exploration of exposure-time-
response relationships and the assessment of potential
modifying factors. Evidence on radon and lung cancer
became available from many different epidemiologic stu-
dies of underground miners including 11 studies that
had quantitative exposure information suitable for
pooled analysis to estimate the exposure-response rela-
tionship between exposure to radon progeny and lung
cancer risk. These data were assembled in the early
1990s by Lubin et al. [16]; the pooled data set included
more than 2,700 lung cancer deaths among 68,000
miners followed for nearly 1.2 million person-years of
observation. A time-dependent risk model was devel-
oped by Lubin et al [16] and then extended by the BEIR
VI Committee [11]. Conceptually, the BEIR VI Commit-
tee followed the approach used a decade earlier by the
BEIR IV Committee, i.e., developing an empiric, time-
dependent model for lung cancer risk from the miner
data.
Most analyses were based on a linear excess relative
risk (ERR) model:
RR = 1 + ßw or ERR = ßw,
where RR is relative risk, ß is a parameter measuring
the unit increase in ERR per unit increase in w, and w
is cumulative exposure to radon progeny. As in the
BEIR IV analysis, ERR was linearly related to cumulative
exposure to radon progeny without threshold. The ERR
per unit exposure varied significantly with other factors;
it decreased with attained age, time since exposure, and
time after cessation of exposure but was not affected
significantly by age at first exposure. Synergism with
tobacco smoking was documented in analyses of data
from the cohorts with smoking information available,
but the interaction was submultiplicative. Over a wide
range of total cumulative exposures to radon progeny,
lung cancer risk increased as exposure rate declined,
supporting the prior hypothesis of an inverse dose-rate
effect [17]. The inverse dose-rate effect implies that the
lower rates of exposure, typical of homes, could increase
risk more than projected from estimates made at the
generally higher exposures in mines. The extent of the
information available at lower levels of exposure per-
mitted analyses of risks in a range of exposures of great-
est relevance to exposures associated with indoor radon.
With the data restricted to the lower end of cumulative
exposures, below 200 WLM, there was no evidence for
departure from a linear model. The BEIR VI risk model
was useful for estimating risks to miners and, by down-
ward extrapolation, for estimating risks to the general
population from indoor radon.
Because the first estimates of the lung cancer risk
associated with indoor radon were based on the epide-
miological studies of miners, the attendant uncertainties
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cancer in the general population. The initial studies
were ecological and inherently limited such that multi-
ple case-control studies were initiated subsequently.
One ecological study, however, merits consideration
b e c a u s ei t sf i n d i n g sw e r ec o n s i d e r e db ys o m ea sc o u n -
tering the linear no-threshold models that had been
applied to the miner data. The US ecological study car-
ried out and extended periodically by Cohen [18,19] was
widely cited across the 1980’s and 1990’sb e c a u s eo ft h e
finding of an inverse relationship between county-level
radon average concentrations and lung cancer mortality.
Critics of radon control programs referred to this study
in characterizing the evidence on radon and lung cancer
as too uncertain to warrant national programs [20].
However, the inherent flaws of the Cohen study were
not acknowledged by either these critics or Cohen him-
self, although catalogued by the BEIR Committees and
by Stidley and Samet in 1993 [21].
Cohen continued to publish ecological analyses on
radon and lung cancer, using multivariate models with
multiple factors in an attempt to control confounding
[22]. An analysis by Puskin [23] provided strong indica-
tion of confounding by smoking. Puskin examined cor-
relations of county mortality rates for other smoking-
related cancers with county average radon levels and
found negative correlations, as shown for lung cancer, a
pattern indicating uncontrolled confounding by smok-
ing. A review carried out by a scientific committee of
the National Council on Radiation Protection and Mea-
surements reached a similar conclusion [24]. The long-
standing discussion of the Cohen analyses and their
utilization in policy discussions reflects the willingness
of some to use data that are flawed but consistent with
a policy objective.
The initial wave of ecological studies was soon sup-
planted by case-control studies of lung cancer carried
out in the general population to directly estimate the
risk. The principal methodological problem in these stu-
dies was estimating domestic radon exposure during the
relevant time span, possibly extending across the full
lifespan. In some early studies, exposures were indirectly
estimated based on surrogates such as type of residential
construction or residence location [15]. In the more
recent studies, exposures to indoor radon were esti-
mated by making longer-term measurements of radon
concentration in the current and previous residences of
the cases and controls [11]. Several of the studies have
been restricted to nonsmokers or long-term former
smokers in order to estimate the lung cancer risk in this
group as precisely as possible. A substantial number of
these case-control studies were carried out in North
America and Europe and the results reported from the
1980’s forward.
As the initial findings were reported and new studies
were initiated, potential limitations of the individual stu-
dies were reported. A need for pooling of study results
was predicted based on sample size calculations pub-
lished by Lubin et al. in 1990 [25]. The sample size cal-
culations considered the consequences of measurement
error and residential mobility, which together tend to
reduce the variability of population exposure. The calcu-
lations indicated that the total sample size needed for
hypotheses of interest approached the total number of
cases from the completed and the then ongoing studies,
approximately 15,000. An update of these calculations
[26] confirmed the need for large sample sizes and this
recognition led to a prospective plan for pooling of the
various studies to achieve the maximum statistical
power.
In 2005, the results of pooled analyses of data from
North America [27] and from Europe [28] were
reported. The North American analysis included data
from seven studies with 3,662 cases and 4,966 controls.
The risk of lung cancer was estimated to increase by
11% (95% CI 0-28%) per 100 Bq m
-3 increment in the
concentration at which exposure occurs in a home. The
estimate from the pooling of 13 European studies invol-
ving 7,148 cases and 14,208 controls was similar: an
increment of 8% (95% CI 3-16%) per 100 Bq m
-3 incre-
ment in home concentration was estimated. The esti-
mates from the two pooled analyses are comparable and
are close to estimates projected models based in the
data from underground miners. There was no indication
that the risk of radon varied across a number of poten-
tial modifiers, such as age and smoking (Figure 2). The
global pooling will be completed within the year.
Thus, the evidence on radon and lung cancer risk is
substantial and coherent and indoor radon is widely
considered to be carcinogenic. Nonetheless, some
remain skeptical, perhaps primarily because of the adop-
tion of a no-threshold relationship between lung cancer
risk and radon exposure. Critics of this model and of
radon control initiatives have turned to the results of
one recent study as providing countering evidence. In a
case-control study in Massachusetts, Thompson and
colleagues [29] estimated exposure to radon for 200
cases and 397 controls; overall, they did not find an
association between estimated radon exposure and lung
cancer risk and, in fact, the risk dipped at the higher
levels. In spite of the already accumulated epidemiologi-
cal evidence, including the two pooled analyses and the
strong biophysical basis for radon-induced carcinogen-
esis at any level of exposure, the results of this study
were used to question the linear, no-threshold relation-
ship of radon with lung cancer risk [30,31]. In fact,
Scott et al. stated “Based on the results presented, we
can therefore state that for people residing in homes
Samet Environmental Health 2011, 10(Suppl 1):S4
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-3 increase in measured radon concentration in 13 European case-control studies Source:
Darby et al. 2005 [28].
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−3
(0.676 − 6.76 pCi L
−1), remediation of their homes to
eliminate radon may lead to a substantial increase in
their lung cancer risk!”[30].
The example of radon and lung cancer provides a
number of “lessons learned” concerning the use of epi-
demiological evidence to control cancer. First, the iden-
tification of unacceptable levels of lung cancer risk was
readily identified in single cohorts of highly exposed
underground miners. Second, as exposures came under
control, there was a need to characterize the exposure-
response relationship so as to set workplace standards
with an acceptable level of risk. The individual studies
did not provide a robust data base for this purpose, but
the pooled data bases did. Third, as for other exposures,
extrapolations of the exposure-response relationship
observed in underground miners to the general popula-
tion were subject to substantial uncertainty and that
uncertainty entered into policy discussions. Fourth, the
prospective plan for pooling of the indoor radon studies
l e dt ot h em o s ti n f o r m a t i v ed a t ab a s ep o s s i b l ef r o mt h e
diverse under-powered studies that were implemented.
Fifth, integrative syntheses of epidemiological evidence
with other research findings, as carried out by the BEIR
Committees, are critical for robust interpretation of epi-
demiological evidence. Sixth, even very strong evidence
and scientific consensus may not quiet all critics, parti-
cularly those motivated by the policy implications of the
scientific evidence. In the example of radon, critics con-
tinued to claim that uncertainties abound, even as the
evidence became firmer [32].
The continuing need for epidemiological research
Turning to radiation generally, a century after we
learned that radiation can cause cancer and with a half-
century of accumulated observational evidence on the
risks of radiation, why is more research needed? Two
main reasons can be cited: 1) the need for an ever
stronger base of evidence on the risks of radiation to
protect the public and workers from unnecessary risk of
cancer; and 2) the exposure of the population to new
forms of radiation for which information on risks is still
uncertain. Additionally, the emergence of genomics
offers the possibility of identifying genetic determinants
of risk, leading to the prospect of identifying those at
high risk for cancer caused by therapeutic irradiation.
Additionally, debate about the nature of the cancer risk
associated with radiation has become almost ideological
on some matters, such as the nature of the dose-
response relationship, and further evidence may help to
bring this distracting debate to a close.
The “low-dose” controversy persists and will likely
remain, absent a new level of mechanistic understanding
that identifies the biophysical process underlying
radiation carcinogenesis with even greater certainty.
Even for radon progeny for which a high level of cer-
tainty on the mechanism of DNA damage by alpha par-
ticles has been reached, there is still debate on risks at
lower levels. A recent point-counterpoint in Radiology is
illustrative. Little and colleagues [33], under the title–
"Risks Associated with Low Doses and Low Dose Rate
of Ionizing Radiation: Why Linearity May be (Almost)
t h eB e s tT h a tW eC a nD o " –conclude that the evidence
on biological mechanisms weighs against any possible
hormesis and the existence of a threshold. A similar
conclusion was reached in the 2003 in an evidence
synthesis carried out by leading researchers on the topic
[34]. Tubiana and colleagues [35] in their counterpoint
entitled——“The Linear No-Threshold Relationship Is
inconsistent with Radiation Biologic and Experimental
Data”–find indication of hormesis and evidence against
a no-threshold relationship. They propose that repair
mechanisms are in-place and that adaptive responses
are beneficial, i.e., hormetic. They view the epidemiolo-
gical evidence as failing to demonstrate carcinogenesis
at lower doses of low linear energy transfer radiation.
Their arguments move to the policy and specific radia-
tion protection implications of a risk relationship that is
linear without threshold.
Further epidemiological research is unlikely to bring
this now-lengthy discussion to closure. At lower doses,
even large data sets are not informative as to alternative
forms of the exposure-response relationship. Addition-
ally, as the range of evidence extends to lower doses,
critics will likely continue to claim uncertainty, but at
ever lower doses. The combination of more robust epi-
demiological evidence and deepening mechanistic
understanding may eventually silence critics, as has
apparently occurred with radon.
The more recent debate concerning potential risks of
high frequency electromagnetic radiation from cell
phones illustrates another need for further research: the
emergence of a nearly ubiquitous exposure with uncer-
tain consequences. Cell phone ownership has surged
over the last 20 years, with worldwide penetration. As
the technology and making calls have become cheaper,
usage has surged. Children now have cell phones from
an early age and ever-increasing amounts of time are
spent using them. Public concern about the possibility
of carcinogenesis by electromagnetic radiation generally,
like that emitted by cell phones is not new [36-39].
From the mid-1970s, studies had been carried out on
low frequency electromagnetic radiation generated by
power lines and most notably childhood leukemias, but
on other malignancies as well [36,39]. For cell phones,
the concern has been specifically with brain cancer,
since the brain is exposed to electromagnetic radiation
during cell phone use. Other sites are of concern as
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but there are fewer studies of those sites because of the
low incidence rates for these malignancies.
Even in the 1990s, although exposures of users were of
relatively brief duration, epidemiological studies were
initiated. The case-control design was used to compare
cell phone use of people with brain cancer with use by
controls. Inskip and colleagues, for example, at the U.S.
National Cancer Institute carried out a multi-site case-
control study that was reported in the New England Jour-
nal of Medicine[40]. The International Agency for
Research on Cancer (IARC) organized a multisite study,
the INTERPHONE study, involving 13 countries [41].
The overall findings were published in June 2010 [42],
although some of the component sites had reported their
findings (see selected articles by INTERPHONE groups
in Sweden [43], Denmark [44], Germany [45], the U.K.
[46], and Norway [47]). The findings of the component
sites provided mixed evidence; publication of the long-
awaited multi-site findings also left the question open as
to whether cell phones cause brain cancer [42,48].
Further research is also needed because of the poten-
tial for “surprises”. For example, the Chernobyl disaster
was shortly followed by an epidemic of thyroid cancer
among children, an epidemic that was not anticipated
based on then extent epidemiological data and knowl-
edge of the radionuclides to which the children were
exposed [49]. Changing patterns of medical exposure
are also of concern, as diagnostic imaging is more
widely applied and at young ages. Notably, medical irra-
diation now comprises the largest proportion of the
radiation received by the US population, surpassing
radon [8]. For some groups, such as children with cystic
fibrosis, medical monitoring with CAT scans may lead
to sustained exposure from an early age [50].
Finally, there is the major scientific opportunity for
identifying genes that increase risk for radiation carcino-
genesis. Investigation of gene X environment interaction
is a burgeoning area of research. Compared with some
other environmental agents to which the public is
broadly exposed, radiation exposure is measured more
feasibly and with greater accuracy. Studies of therapeutic
exposures have the strength of a precisely administered
and recorded dose. The BEIR VII report, the last review
by the US National Research Council, pointed to genet-
ics as an area for further research [51].
Table 1 Radiation agents reviewed in the International Agency for Research on Cancer’s (IARC) monograph series
Agent Group IARC Monograph
Volume No.
Year
Ultraviolet radiation 1 40, 55 1986,
1992
Radon-222 and its decay products 1 43, 78 1988,
2001
Ultraviolet radiation A (NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other relevant data)
2A 55 1992
Ultraviolet radiation B (NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other relevant data)
2A 55 1992
Ultraviolet radiation C (NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other relevant data)
2A 55 1992
Solar radiation 1 55 1992
X- and Gamma (g)-Radiation 1 75 2000
Radium-224 and its decay products 1 78 2001
Radium-226 and its decay products 1 78 2001
Radium-228 and its decay products 1 78 2001
Radioiodines, short-lived isotopes, including iodine-131, from atomic reactor accidents and nuclear
weapons detonation (exposure during childhood)
1 78 2001
Radionuclides, a-particle-emitting, internally deposited (NB: Specific radionuclides for which there is
sufficient evidence for carcinogenicity to humans are also listed individually as Group 1 agents)
1 78 2001
Radionuclides, b-particle-emitting, internally deposited (NB: Specific radionuclides for which there is
sufficient evidence for carcinogenicity to humans are also listed individually as Group 1 agents)
1 78 2001
Magnetic fields (extremely low-frequency) 2B 80 2002
Magnetic fields (static) 3 80 2002
Classification of carcinogenic hazards to humans:
Group 1: Carcinogenic to humans.
Group 2A: Probably carcinogenic to humans.
Group 2B: Possibly carcinogenic to humans.
Group 3: Not classifiable as to carcinogenicity to humans.
Group 4: Probably not carcinogenic to humans.
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best models for carrying out radiation epidemiology
research. The research is inherently multidisciplinary,
drawing on the expertise not only of epidemiologists,
but biostatisticians and risk assessors, health physicists,
and radiation biologists. Studies on the genetic basis of
susceptibility need additional expertise in genetic epide-
miology and genomics. Epidemiological research on
radiation risks is centralized in a small number of cen-
ters worldwide, including the Radiation Epidemiology
Branch of the US National Cancer Institute, the Radia-
tion Effect Research Foundation, and IARC, and several
universities. The field needs to be maintained and
strengthened and transitioned beyond an emphasis on
quantification of risk to integration of genetics in the
search for genes affecting cancer risk associated with
radiation. Epigenetic approaches may also prove useful.
Surveillance approaches based in administrative systems
are also needed to track the consequences of changing
patterns of exposure to medical radiation.
Concluding remarks
While the identification of cigarette smoking as a cause
of lung cancer is touted as one of the key, early suc-
cesses of epidemiological research, cohort studies were
documenting the risk of cancer associated with radiation
during the same decades–the 1950s and 1060s. The
need to move quickly from hazard identification to
dose-response assessment to support radiation standards
development motivated the application of quantitative
models to the epidemiological data. The data from the
LifeSpan Study of Atomic Bomb Survivors provided an
early opportunity for dose-response modeling and the
exploration of dose-response relationships over time.
The example of radiation points to one potential fail-
ing of the IARC Monograph series for control of envir-
onmental carcinogens: the purpose is to assess
carcinogenicity and classify the strength of evidence for
causation, and not to quantify risk associated with a car-
cinogen. However, regulation of many carcinogens is
increasingly based in quantitative risk models. This
restriction of the IARC approach is well recognized, as
are the consequences. A move to developing risk models
would necessitate a different approach by IARC, and
possibly the addition of a group within the Agency that
could carry out the modeling. If IARC were to move in
this direction, building on the legacy of Lorenzo Toma-
tis, radiation would be the right starting point.
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